EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

This list contains a non-exhaustive inventory of substances that fall within the scope of the European Union's definition of hazardous chemical and biological substances, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; and (2) Annex III of Directive 2000/54/EC (Biological Agents). The EU's Occupational Safety and Health (OSH) Framework Directive 89/391/EEC applies to risks arising from chemical, physical and biological agents at the workplace.

Last updated 30 dubna 2024. Database contains 4691 unique substances/entries.

Filter the list

Je zobrazeno 2 801 - 3 000 položek z celkového počtu 4 691.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)
(±)-butan-2-ol;butan-2-ol	201-158-5	15892-23-6;78-92-2	Flam. Liq. 3; Eye Irrit. 2; STOT SE 3
2-methoxypropanol	216-455-5	1589-47-5	Flam. Liq. 3; Repr. 1B; STOT SE 3; Skin Irrit. 2; Eye Dam. 1
1-bromo-2-methylpropyl propionate	422-900-6	158894-67-8	Flam. Liq. 3; Carc. 2; Skin Corr. 1B; Skin Sens. 1
chloralose (INN); (R)-1,2-O-(2,2,2-trichloroethylidene)-α-D-glucofuranose; glucochloralose; anhydroglucochloral	240-016-7	15879-93-3	Acute Tox. 4; Acute Tox. 3; STOT SE 3
mixed linear and branched C14-15 alcohols ethoxylated, reaction product with epichlorohydrin NUPORE G45-10	420-480-9	158570-99-1	Skin Irrit. 2; Skin Sens. 1
nickel tellurium tetraoxide	239-974-9	15852-21-8	Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
nickel tellurium trioxide	239-967-0	15851-52-2	Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
formic acid, nickel salt	239-946-6	15843-02-4	Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
mannitol hexanitrate; nitromannite;mannitol hexanitrate; nitromannite;[>40 % phlegmatiser]	239-924-6	15825-70-4	Expl. 1.1
mannitol hexanitrate; nitromannite;mannitol hexanitrate; nitromannite;[>40 % phlegmatiser]	239-924-6	15825-70-4	Unst. Expl.
trifluralin (ISO) (containing <0.5 ppm NPDA); α, α, α-trifluoro-2,6-dinitro-N, N-dipropyl-p-toluidine (containing; < 0,5 ppm NPDA); 2,6-dinitro-N, N-dipropyl-4-trifluoromethylaniline (containing < 0,5 ppm NPDA); N, N-dipropyl-2,6-dinitro-4-trifluoromethylaniline (containing < 0.5 ppm NPDA)	216-428-8	1582-09-8	Carc. 2; Skin Sens. 1
flonicamid (ISO); N-(cyanomethyl)-4-(trifluoromethyl)pyridine-3-carboxamide	605-127-0	158062-67-0	Acute Tox. 4
nickel triuranium decaoxide	239-876-6	15780-33-3	Carc. 1A; STOT RE 1; Skin Sens. 1
5-{4-[5-amino-2-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-sulfo-phenylamino]-6-chloro-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfo-naphthalen-2-ylazo)-naphthalene-2,7-disulfonicacid sodium salt ROUGE TZ 4075	418-340-7	157707-94-3	Eye Dam. 1
methyl 2-benzylidene-3-oxobutyrate LUGALVAN ES 9571	420-940-9	15768-07-7	Eye Irrit. 2; Skin Irrit. 2
2-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-phenol CG 31-1919	410-760-9	157661-93-3	Skin Irrit. 2; Skin Sens. 1
hexasodium 4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-sulfonatophenylazo)phenylazo]-7,7'[p-phenylenebis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino]]dinaphthalene-2-sulfonate RED SF-PE 3534	410-180-6	157627-99-1	Eye Dam. 1
disodium 5-[5-[4-(5-chloro-2,6-difluoropyrimidin-4-ylamino)benzamido]-2-sulfonatophenylazo]-1-ethyl-6-hydroxy-4-methyl-2-oxo-3-pyridylmethylsulfonate YELLOW DO 2286	412-530-3	157627-98-0	Eye Dam. 1; Skin Sens. 1
toluene-4-sulphonohydrazide	216-407-3	1576-35-8	Self-react. D
2-(4-(4-(butyl-(1-methylhexyl)amino)phenyl)-3-cyano-5-oxo-1,5-dihydropyrrol-2-ylidene)propandinitrile	429-180-2	157362-53-3	Skin Sens. 1
reaction mass of: reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:2); reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:3) T-271	417-980-4	157321-59-0	Self-react. C; Carc. 2
2-phenyl-1,3-propanediol 1,3-PPD	411-810-2	1570-95-2	Eye Dam. 1
4-chloro-o-cresol; 4-chloro-2-methylphenol	216-381-3	1570-64-5	Acute Tox. 3; Skin Corr. 1A
diammonium nickel bis(sulfate)	239-793-5	15699-18-0	Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Resp. Sens. 1; Skin Sens. 1
1-ethoxypropan-2-ol; 2PG1EE; 1-ethoxy-2-propanol; propylene glycol monoethyl ether	216-374-5	1569-02-4	Flam. Liq. 3; STOT SE 3
sodium and potassium 4-(3-aminopropylamino)-2,6-bis[3(4-methoxy-2-sulfophenylazo)4-hydroxy-2-sulfo-7-naphthylamino]-1,3,5-triazine RED ULK 1324	416-280-6	156769-97-0	Skin Sens. 1
sodium 4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzenesulfonate ORANGE JOG 365	416-370-5	156738-27-1	Skin Sens. 1
N-dodecyl-[3-(4-(dimethylamino)benzamido)-propyl]dimethylammonium tosylate DIMETHYLPAPAMIDOLAURDIMONIUM TOSYLATE	421-130-8	156679-41-3	Eye Dam. 1; Skin Sens. 1
6-(1α,5aβ,8aβ,9-pentahydroxy-7β-isopropyl-2β,5β,8β-trimethylperhydro-8bα,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate; ryania	239-732-2	15662-33-6	Acute Tox. 4
2,4,4-trimethylhexamethylene-1,6-di-isocyanate	239-714-4	15646-96-5	Acute Tox. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1
2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropane FRESCOLAT MPC	417-420-9	156324-82-2	Eye Irrit. 2
decarbofuran (ISO); 2,3-dihydro-2-methylbenzofuran-7-yl methylcarbamate	-	1563-67-3	Acute Tox. 3
carbofuran (ISO); 2,3-dihydro-2,2-dimethylbenzofuran-7-yl N-methylcarbamate	216-353-0	1563-66-2	Acute Tox. 2
bis(N-hydroxy-N-nitrosocyclohexylaminato-O,O')copper; bis(N-cyclohexyl-diazenium-dioxy)-copper; [Cu-HDO]	239-703-4	15627-09-5	Flam. Sol. 1; Acute Tox. 4; STOT RE 2; Eye Dam. 1
2-ethyl-2-[[(1-oxoallyl)oxy]methyl]-1,3-propanediyl diacrylate; 2,2-bis(acryloyloxymethyl)butyl acrylate; trimethylolpropane triacrylate	239-701-3	15625-89-5	Carc. 2; Skin Irrit. 2; Eye Irrit. 2; Skin Sens. 1
O, O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime] ASIL-322; OS-5200	421-870-1	156145-66-3	Repr. 2; Acute Tox. 4; STOT RE 2
reaction mass of: 2-methylsulfanyl-4,6-bis-(2-hydroxy-4-methoxy-phenyl)-1,3,5-triazine; 2-(4,6-bis-methylsulfanyl-1,3,5-triazin-2-yl)-5-methoxy-phenol UVA RAR 1018	423-520-3	156137-33-6	Skin Sens. 1
tetrabutylammonium 2-amino-6-iodopurinate	424-710-9	156126-48-6	Acute Tox. 4; STOT RE 2; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
triethyl arsenate TRIETHYLARSENAT; TRIETHYLARSENATE; TRIETHYLARSENATE (TEASAT)	427-700-2	15606-95-8	Carc. 1A; Acute Tox. 3
zoxamide (ISO); (RS)-3,5-dichloro-N-(3-chloro-1-ethyl-1-methyl-2-oxopropyl)-p-toluamide	605-037-1	156052-68-5	Skin Sens. 1
calcium cyanamide	205-861-8	156-62-7	Acute Tox. 4; STOT SE 3; Eye Dam. 1
trans-dichloroethylene	205-860-2	156-60-5	Flam. Liq. 2; Acute Tox. 4
cis-dichloroethylene	205-859-7	156-59-2	Flam. Liq. 2; Acute Tox. 4
4-ethoxyaniline; p-phenetidine	205-855-5	156-43-4	Muta. 2; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
nickel dichromate	239-646-5	15586-38-6	Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate; [DOTE]	239-622-4	15571-58-1	Repr. 1B; STOT RE 1
1-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldiammoniumsulfate PYRAZOL P5; PYRAZOLE DHE	429-300-3	155601-30-2	Eye Dam. 1; Skin Sens. 1
emamectin benzoate (ISO); (4''R)-4''-deoxy-4''-(methylamino) avermectin B1 benzoate	605-015-1	155569-91-8	Acute Tox. 3; STOT SE 1; STOT RE 1; Eye Dam. 1
methyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionate DISPERSE RED CLA 282	416-240-8	155522-12-6	Skin Sens. 1
1,2-bis[4-fluoro-6-{4-sulfo-5-(2-(4-sulfonaphtalene-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaphthalene-7-ylazo)phenylamino}-1,3,5-triazin-2ylamino]ethane; x-sodium, y-potassium salts x = 7,755 y =0,245 REACTIVE NAVY DER 7678	417-610-1	155522-09-1	Skin Sens. 1
chlorotoluron (ISO); 3-(3-chloro-p-tolyl)-1,1-dimethylurea	239-592-2	15545-48-9	Carc. 2; Repr. 2
sodium 3,5-bis(tetradecyloxycarbonyl)benzenesulfinate AF-390	407-720-8	155160-86-4	Skin Sens. 1
1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone methanesulfonate	431-010-7	154486-26-7	Acute Tox. 4; Eye Dam. 1
potassium sodium 6,13-dichloro-3,10-bis{2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate SUMIFIX BRILLIANTBLAU GL KONZENTRAT	414-100-0	154336-20-6	Eye Dam. 1
2-isopropyl-4-(N-methyl)aminomethylthiazole A-87463.0	414-800-6	154212-60-9	Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1
androsta-1,4,9(11)-triene-3,17-dione	433-560-3	15375-21-0	Repr. 2
N-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine	431-060-1	153719-38-1	Acute Tox. 4; Skin Sens. 1
thiamethoxam (ISO); 3-(2-chloro-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine	428-650-4	153719-23-4	Repr. 2; Acute Tox. 4
potassium bis(N-carboxymethyl)-N-methyl-glycinato-(2-)N, O,O, N)-ferrate-(1-)monohydrate CHEMICAL CHELATING AGENT #2	411-640-9	153352-59-1	Acute Tox. 4
5-(2-bromophenyl)-2-tert-butyl-2H-tetrazole WAY-128170	420-820-6	153042-18-3	Flam. Liq. 3; Acute Tox. 4
2-(4-aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazole FC-102B; M-3218	415-910-7	152828-25-6	Skin Sens. 1
N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide	423-530-8	152828-23-4	STOT RE 1; Acute Tox. 4
3-chloro-6-cyano-bicyclo(2,2,1)heptan-2-one-O-(N-methylcarbamoyl)oxime; triamid	-	15271-41-7	Acute Tox. 2; Acute Tox. 3
1-(3-cyclopentyloxy-4-methoxyphenyl)-4-oxo-cyclohexanecarbonitrile	427-450-4	152630-47-2	Acute Tox. 4; STOT RE 2; Skin Sens. 1
cartap hydrochloride	239-309-2	15263-52-2	Acute Tox. 4
methyl-5-nitrophenyl-guanidine	435-500-1	152460-07-6	Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
lead 2,4,6-trinitro-m-phenylene dioxide; lead 2,4,6-trinitroresorcinoxide; lead styphnate;lead 2,4,6-trinitro-m-phenylene dioxide; lead 2,4,6-trinitroresorcinoxide; lead styphnate (≥ 20 % phlegmatiser)	239-290-0	15245-44-0	Unst. Expl.; Repr. 1A; Acute Tox. 4; STOT RE 2
lead 2,4,6-trinitro-m-phenylene dioxide; lead 2,4,6-trinitroresorcinoxide; lead styphnate;lead 2,4,6-trinitro-m-phenylene dioxide; lead 2,4,6-trinitroresorcinoxide; lead styphnate (≥ 20 % phlegmatiser)	239-290-0	15245-44-0	Expl. 1.1; Repr. 1A; Acute Tox. 4; STOT RE 2
3-bromo-2,2-bis(bromomethyl)propan1-ol	622-370-8	1522-92-5	Carc. 1B; Muta. 2
schradan (ISO); octamethylpyrophosphoramide	205-801-0	152-16-9	Acute Tox. 1; Acute Tox. 2
4,4'-bis(N-carbamoyl-4-methylbenzenesulfonamide)diphenylmethane B-TUM	418-770-5	151882-81-4	Carc. 2
3-benzyl-exo-6-nitro-2,4-dioxo-3-aza-cis-bicyclo[3.1.0]hexane	426-750-2	151860-15-0	Skin Sens. 1
2-[2-hydroxy-3-(2-chlorophenyl)carbamoyl-1-naphthylazo]-7-[2-hydroxy-3-(3-methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-one P-964	420-580-2	151798-26-4	Repr. 1B
dichlorprop-P (ISO); (+)-R-2-(2,4-dichlorophenoxy)propionic acid D-2,4-DP; DICHLORPROP-P; DUPLOSAN DP-ACID	403-980-1	15165-67-0	Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
morpholine-4-carbonyl chloride	239-213-0	15159-40-7	Carc. 2; Eye Irrit. 2; Skin Irrit. 2
hexasodium (di[N-(3-(4-[5-(5-amino-3-methyl-1-phenylpyrazol-4-yl-azo)-2,4-disulfo-anilino]-6-chloro-1,3,5-triazin-2-ylamino)phenyl)-sulfamoyl](di-sulfo)-phthalocyaninato)nickel PROCION EMERALD H-EXL COLOUR; SUBSTANCE S156718	417-250-5	151436-99-6	Eye Dam. 1; Skin Sens. 1
2-[N-ethyl-4-[(5-nitrothiazol-2-yl)azo]-m-toluidino]ethyl acetate; C.I. Disperse Blue 124	239-203-6	15141-18-1	Skin Sens. 1A
2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride SR 48001 A	424-560-4	151257-01-1	Acute Tox. 4; Eye Irrit. 2
(4aS-cis-)-6-benzyl-octahydropyrrolo[3.4-b]pyridine	425-930-8	151213-39-7	Skin Corr. 1B; Acute Tox. 4; STOT RE 2
E-ethyl-4-oxo-4-phenylcrotonate BAE; BENZOYLACRYLATE D'ETHYLE; BENZOYLACRYLATE D'ÉTHYLE (TRANS); BENZOYLACRYLIC ACID ETHYL ESTER; BENZOYLACRYLSÄURE ETHYLESTER	408-040-4	15121-89-8	Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
sodium perborate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];sodium perborate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	239-172-9	15120-21-5	Ox. Sol. 2; Repr. 1B; Acute Tox. 3; Acute Tox. 4; STOT SE 3; Eye Dam. 1
sodium perborate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];sodium perborate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	239-172-9	15120-21-5	Ox. Sol. 2; Repr. 1B; Acute Tox. 4; STOT SE 3; Eye Dam. 1
reaction mass of isomers of branched tetracosane 1-DODECENE DIMER, HYDROGENATED; ALKANE 2	417-060-2	151006-61-0	Acute Tox. 4
reaction mass of: branched icosane; branched docosane; branched tetracosane	417-050-8	151006-58-5	Acute Tox. 4
ethyleneimine; aziridine	205-793-9	151-56-4	Flam. Liq. 2; Carc. 1B; Muta. 1B; Acute Tox. 2; Acute Tox. 1; Skin Corr. 1B
trisodium hexafluoroaluminate(cryolite)	239-148-8	15096-52-3	STOT RE 1; Acute Tox. 4
2-amino-4-bromo-5-chlorobenzoic acid ACIDE CÉBRANILIQUE	424-700-4	150812-32-1	Eye Dam. 1
nickel selenate	239-125-2	15060-62-5	Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
sodium [29H,31H-phthalocyaninato-(2-)-N29,N30,N31,N32]-((3-(N-methyl-N-(2-hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonato, copper complex DIRECT BLUE CA 36133	412-730-0	150522-10-4	Skin Corr. 1B
p-tolyl 4-chlorobenzoate UP 565	411-530-0	15024-10-9	Skin Sens. 1
diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate	422-670-7	150202-11-2	Repr. 2; Acute Tox. 3; STOT RE 2
mequinol; 4-methoxyphenol; hydroquinone monomethyl ether	205-769-8	150-76-5	Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
monuron (ISO); 3-(4-chlorophenyl)-1,1-dimethylurea	205-766-1	150-68-5	Carc. 2; Acute Tox. 4
nickel acetate	239-086-1	14998-37-9	Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Resp. Sens. 1; Skin Sens. 1
tepraloxydim (ISO); (RS)-(EZ)-2-{1-[(2E)-3-chloroallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one	604-715-4	149979-41-9	Carc. 2; Repr. 2
dimoxystrobin (ISO); (2E)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide; (E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide	604-712-8	149961-52-4	Carc. 2; Repr. 2; Acute Tox. 4
bifenazate (ISO); isopropyl 2-(4-methoxybiphenyl-3-yl)hydrazinecarboxylate	442-820-5	149877-41-8	STOT RE 2; Skin Sens. 1
sodium 1,2-bis[4-[4-{4-(4-sulfophenylazo)-2-sulfophenylazo}-2-ureido-phenyl-amino]-6-fluoro-1,3,5-triazin-2-ylamino]-propane, sodium salt REACTIVE ORANGE TZ 3931	413-990-8	149850-31-7	Skin Sens. 1
methyl N-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinate FAT 40'489	413-040-2	149850-30-6	Skin Sens. 1
1,3-bis{6-fluoro-4-[1,5-disulfo-4-(3-aminocarbonyl-1-ethyl-6-hydroxy-4-methyl-pyrid-2-on-5-ylazo)-phenyl-2-ylamino]-1,3,5-triazin-2-ylamino}propane lithium-, sodium salt JAUNE REACTIF MUB 151	415-100-3	149850-29-3	Skin Sens. 1
chromyl dichloride; chromic oxychloride	239-056-8	14977-61-8	Ox. Liq. 1; Carc. 1B; Muta. 1B; Skin Corr. 1A; Skin Sens. 1
N,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propanediamide QUESTAMIDE H	422-560-9	149591-38-8	Repr. 2; Eye Irrit. 2
lithium sodium (4-((5-chloro-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulfonato(3-)) chromate(2-) ACID RED FC 70013	414-250-7	149564-66-9	Acute Tox. 4; Eye Dam. 1
trilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalenesulfonato(3-))chromate(3-) ACID BLUE FC 77890	414-290-5	149564-65-8	Acute Tox. 4
disodium 1-amino-4-(2-(5-chloro-6-fluoro-pyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro-anthracene-2-sulfonate REACTIVE BLUE FC 60866	414-040-5	149530-93-8	Acute Tox. 4; Skin Sens. 1
(S)-N-tert-butyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide CZ-AMIDE; PTH-TETRAHYDROAMIDE; TETRAHYDROAMIDE (THA)	414-600-9	149182-72-9	Acute Tox. 4
2-(4-(5,6(or 6,7)-dichloro-1,3-benzothiazol-2-ylazo)-N-methyl-m-toluidino)ethyl acetate BRILLANT RED 1047729; BRILLIANT RED 1047729; ROUGE BRILLANT 1047729	405-440-0	149172-69-0	Skin Sens. 1
zinc 2-hydroxy-5-C13-18 alkylbenzoate Z-6	402-280-3	149144-82-1	Eye Irrit. 2; Skin Irrit. 2
hydrazine-trinitromethane	-	14913-74-7	Expl. 1.1; Self-react. A; Carc. 1B; Acute Tox. 3; Skin Sens. 1
N-cyclohexyl-S, S-dioxo; benzo[b]tiophene-2-carboxamide PREVENTOL VP OC 3061	423-990-1	149118-66-1	Acute Tox. 4; Eye Dam. 1
tetrasodium 5-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalene-1,2,5,7-disulphonate C.I. REACTIVE RED 219	400-130-1	149057-72-7	Resp. Sens. 1
(ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised AOC 1020X	402-370-2	149057-70-5	Flam. Liq. 3; Eye Dam. 1
bis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-ylidene)dimethylammonium) sulfate SAFRANIN SHMN	406-770-8	149057-64-7	STOT RE 2; Eye Dam. 1; Skin Sens. 1
benzothiazole-2-thiol	205-736-8	149-30-4	Skin Sens. 1
disul (ISO); 2-(2,4-dichlorophenoxy)ethyl hydrogensulphate; 2,4-DES	205-259-5	149-26-8	Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1
(R)-butan-2-ol	238-967-8	14898-79-4	Flam. Liq. 3; Eye Irrit. 2; STOT SE 3
tetrasodium 4-[4-chloro-6-(4-methyl-2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5-dimethyl-2-sulfophenylazo)-5-hydroxynaphthalene-2,7-disulfonate AZO MONOCHLOROTRIAZINYL REACTIVE DYE; PROCION RED PX-6B COLOUR; SUBSTANCE S161057	415-400-4	148878-22-2	Eye Dam. 1; Skin Sens. 1
octasodium 2-(6-(4-chloro-6-(3-(N-methyl-N-(4-chloro-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalene-1,5-disulfonate PROCION BRILLIANT ORANGE H-EXL; S156745	412-960-1	148878-21-1	Eye Dam. 1; Skin Sens. 1
reaction mass of: tetrasodium 7-(4-[4-chloro-6-[methyl-(3-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate; tetrasodium 7-(4-[4-chloro-6-[methyl-(4-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate (1:1) PROCION YELLOW PX-R; S154357; SUBSTANCE S154357	412-940-2	148878-18-6	Skin Sens. 1
1-bromo-9-(4,4,5,5,5-pentafluoropentylthio)nonane BROMIDE 182,780	422-850-5	148757-89-5	Skin Sens. 1
dinickel hexacyanoferrate	238-946-3	14874-78-3	Carc. 1A; STOT RE 1; Skin Sens. 1
tetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanine-a, b,d-trisulfonato(6-))nickelato II, where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4 and 2 respectively BRILLANTGREEN K-RWA 6083; BRILLIANT GREEN K-RWA 6083	410-160-7	148732-74-5	Eye Irrit. 2; Skin Sens. 1
spirodiclofen (ISO); 3-(2,4-dichlorophenyl)-2-oxo-1-oxaspiro[4.5]dec-3-en-4-yl 2,2-dimethylbutyrate	604-636-5	148477-71-8	Carc. 1B; Repr. 2; STOT RE 2; Skin Sens. 1B
hydrazine bis(3-carboxy-4-hydroxybenzensulfonate) STABO-FIX	405-030-1	148434-03-1	Carc. 1B; Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1
potassium iron(III) 1,3-propanediamine-N, N,N',N'-tetraacetate hemihydrate FEKPDTA; KFEPDTA	405-680-6	148434-01-9	Self-heat. 2
9-vinylcarbazole	216-055-0	1484-13-5	Muta. 2; Acute Tox. 4; Skin Irrit. 2; Skin Sens. 1
isobutylidene-(2-(2-isopropyl-4,4-dimethyloxazolidine-3-yl)-1,1-dimethylethyl)amine ZOLDINE RD-4	419-850-2	148348-13-4	Skin Corr. 1B
diethyl 2,4-dihydroxycyclodisiloxane-2,4-diylbis(trimethylene)diphosphonate, tetrasodium salt, reaction products with disodium metasilicate SIFOSIL; SIFOSIL KONZENTRAT G 96-00 FEST	401-770-4	148324-78-1	Skin Corr. 1B; Acute Tox. 4
hydrogen sodium N-carboxylatoethyl-N-octadec-9-enylmaleamate 2-BUTANEDIOIC ACID, MONOAMIDE WITH N-(9-OCTADECENYL)-3-AMINO	402-970-4	148292-42-6	Skin Sens. 1
2-methyl-1-pentylpyridinium bromide ENS 125	402-690-2	148292-41-5	Acute Tox. 4
calcium octadecylxylenesulphonate Z 7	402-040-8	148262-93-5	Skin Corr. 1B
phoxim (ISO); α-(diethoxyphosphinothioylimino) phenylacetonitrile	238-887-3	14816-18-3	Repr. 2; Acute Tox. 4; Skin Sens. 1
4,4,5,5,5-pentafluoropentan-1-ol	421-360-9	148043-73-6	Acute Tox. 4
quinolin-8-ol; 8-hydroxyquinoline	205-711-1	148-24-3	Repr. 1B; Acute Tox. 3; Eye Dam. 1; Skin Sens. 1
4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene] diphenol; bisphenol AF	216-036-7	1478-61-1	Repr. 1B
reaction mass of: disodium hexyldiphenyl ether disulphonate; disodium dihexyldiphenyl ether disulphonate DOWFAX (R) DRY HYDROTROPE POWDER	429-650-7	147732-60-3	Eye Irrit. 2
sodium 3-(2-acetamido-4-(4-(2-hydroxybutoxy)phenylazo)phenylazo)benzenesulfonate YELLOW E-JD 3442	410-150-2	147703-65-9	Skin Sens. 1
disodium 7-[4-chloro-6-(N-ethyl-o-toluidino)-1,3,5-triazin2-ylamino]-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)2-naphthalenesulfonate SCARLET X-GA 1491	410-390-8	147703-64-8	Eye Dam. 1
4-(2-cyano-3-phenylamino acryloyloxymethyl)-cyclohexyl-methyl 2-cyano-3-phenylamino)-acrylate LICHTSCHUTZMITTEL 1071	413-510-7	147374-67-2	STOT RE 2; Skin Sens. 1
nickel chromate	238-766-5	14721-18-7	Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
reaction products of: trimethylhexamethylene diamine (a mixture of 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6-hexanediamine, EINECS listed), Epoxide 8 (mono[(C10-C16-alkyloxy)methyl]oxirane derivatives) and p-toluene-sulfonic acid FCC 963	410-880-1	147170-38-5	Acute Tox. 4; Skin Corr. 1B
trans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol, 7,7-dioxide FC4010	417-290-3	147086-81-5	Acute Tox. 4
nickel bis(tetrafluoroborate)	238-753-4	14708-14-6	Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
reaction mass of: trans-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid; cis-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid ACETOXYACID	411-660-8	147027-04-1	Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
2-ethoxyethyl 2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl-1,5-dioxaindacen-3-yl)phenoxy)acetate C.I. DISPERSE RED 367	403-960-2	147014-52-6	Skin Sens. 1
N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide; (4-acetamido-2,2,6,6-tetra; methyl-1-piperidinyl)oxidanyl	423-840-3	14691-89-5	Acute Tox. 4
dimexano(ISO); bis(methoxythiocarbonyl) disulphide	215-993-8	1468-37-7	Acute Tox. 4
3-hydroxy-1,1-dimethylbutyl 2-ethyl-2-methylheptaneperoxoate LUPEROX 610-E-35; LUPEROX 610-E-50; LUPEROX 610-EN-50; LUPEROX 610-M-50; LUPERSOL 610; LUPERSOL 610-M-50	413-910-1	1467668-33-2	Org. Perox. C; Flam. Liq. 3; Skin Irrit. 2
3-(hydroxyphenylphosphinyl)propanoic acid FYROL 3-HPP; HIRETAR-205; PHOSGARD PF 100	411-200-6	14657-64-8	Eye Dam. 1
4-methyl-N-(methylsulfonyl)benzenesulfonamide POWDERLINK (R) MTSI	415-040-8	14653-91-9	Acute Tox. 4; STOT SE 3; Eye Dam. 1
2,2'-bioxirane; 1,2:3,4-diepoxybutane	215-979-1	1464-53-5	Carc. 1B; Muta. 1B; Acute Tox. 2; Acute Tox. 3; Skin Corr. 1B
sodium 2-(4-(4-fluoro-6-(2-sulfo-ethylamino)-[1,3,5]triazin-2-ylamino)-2-ureido-phenylazo)-5-(4-sulfophenylazo)benzene-1-sulfonate FAT 40'436; FAT 40'436/A; REACTIVE ORANGE TZ 3538	410-770-3	146177-84-6	Skin Sens. 1
2-amino-4-dimethylamino-6-trifluoroethoxy-1,3,5-triazine	415-500-8	145963-84-4	Acute Tox. 4; STOT RE 2
nickel dibromate	238-596-1	14550-87-9	Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
3-methylpyrazole	215-925-7	1453-58-3	Repr. 1B; Acute Tox. 4; STOT RE 2; Skin Corr. 1; Eye Dam. 1
2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate	433-910-5	145153-52-2	Skin Sens. 1
nickel bis(phosphinate)	238-511-8	14507-36-9	Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxide CGI 403	412-010-6	145052-34-2	Skin Sens. 1
endothal (ISO); 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylic acid	205-660-5	145-73-3	Acute Tox. 3; Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
tetracyclohexylstannane	215-910-5	1449-55-4	Acute Tox. 4
ferbam (ISO); iron tris(dimethyldithiocarbamate)	238-484-2	14484-64-1	Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
methyl 2-aminosulfonyl-6-(trifluoromethyl)pyridine-3-c arboxylate JE 127	421-220-7	144740-59-0	Skin Sens. 1
α[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]-ω nonylphenoxy)poly[oxo(methyl-1,2-ethanediyl)] PC-709	413-420-8	144736-29-8	Skin Corr. 1B; Skin Sens. 1
oxasulfuron (ISO); oxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)-carbamoylsulfamoyl]benzoate	604-430-5	144651-06-9	STOT RE 2
dinickel diphosphate	238-426-6	14448-18-1	Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
chlorfenprop-methyl; methyl 2-chloro-3-(4-chlorophenyl)propionate	238-413-5	14437-17-3	Acute Tox. 4
(R, S)-2-amino-3,3-dimethylbutane amide	447-860-7	144177-62-8	Repr. 2; STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
reaction mass of (S)-Indoxacarb and (R)-Indoxacarb 75:25; methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [2]	604-398-2	144171-61-9	Acute Tox. 3; Acute Tox. 4; STOT RE 1; Skin Sens. 1B
2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate	444-250-2	144111-81-9	Self-react. C
oxalic acid	205-634-3	144-62-7	Acute Tox. 4
fluoroacetic acid	205-631-7	144-49-0	Acute Tox. 2
morphothion (ISO); O, O-dimethyl-S-(morpholinocarbonylmethyl) phosphorodithioate	205-628-0	144-41-2	Acute Tox. 3
bis(hydrogenated tallow C16-18-alkyl)hydroxylamine	418-370-0	143925-92-2	Skin Sens. 1
3-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine ZOLDINE MS-PLUS	421-150-7	143860-04-2	Repr. 1B; Skin Corr. 1B
(2E)-3-phenylprop-2-enal	604-377-8	14371-10-9	Skin Sens. 1A
tetrasodium 1,2-bis(4-fluoro-6- [5-(1-amino-2-sulfonatoanthrachinon-4-ylamino)-2,4,6- trimethyl-3-sulfonatopheny lamino]-1,3,5-triazin-2- ylamino)ethane BLEU REACTIF TZ 3533; BLEU REACTIVE TZ 3533; FAT 41'017/A; REACTIVE BLUE TZ 3533	411-240-4	143683-23-2	Skin Sens. 1
1,3-dichloro-4-fluorobenzene 1,3-DICHLOR-4-FLUORBENZOL; B-7	406-160-1	1435-48-9	Acute Tox. 4; STOT RE 2; Skin Irrit. 2
ethyl 2-carboxy-3-(2-thienyl)propionate SB-201999	415-680-8	143468-96-6	Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
5-acetoxy-2-(R, S)butyryloxymethyl-1,3-oxathiolane	433-530-1	143446-73-5	Acute Tox. 4; Skin Sens. 1
kresoxim-methyl (ISO); methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate	604-351-6	143390-89-0	Carc. 2
(R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole UK-111,975	422-390-5	143322-57-0	Repr. 2; STOT RE 1; Acute Tox. 4; Skin Sens. 1
nickel hydrogen phosphate	238-278-2	14332-34-4	Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
zinc bis(diethyldithiocarbamate)	238-270-9	14324-55-1	Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1
chlordecone (ISO); perchloropentacyclo[5,3,0,02,6,03,9,0 4,8]decan-5-one; decachloropentacyclo[5,2,1,02,6,03,9,05,8]decan-4-one	205-601-3	143-50-0	Carc. 2; Acute Tox. 3
bis(2-(2-methoxyethoxy)ethyl)ether; tetraglyme	205-594-7	143-24-8	Repr. 1B
2-[2-(2-butoxyethoxy)ethoxy]ethanol; TEGBE; triethylene glycol monobutylether; butoxytriethylene glycol	205-592-6	143-22-6	Eye Dam. 1
cinidon ethyl (ISO); ethyl (Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate	604-318-6	142891-20-1	Carc. 2; Skin Sens. 1
(2,3-dimethylbut-2-yl)-trimethoxysilane	439-360-2	142877-45-0	Skin Irrit. 2; Eye Dam. 1
N-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide UM-229	407-070-5	142859-67-4	Skin Sens. 1
3-(cis-3-hexenyloxy)propanenitril PARMANYL	415-220-6	142653-61-0	Acute Tox. 3; Acute Tox. 4
fenazaflor (ISO); phenyl 5,6-dichloro-2-trifluor-omethylbenzimidazole-1-carboxylate	238-134-9	14255-88-0	Acute Tox. 4
tritosulfuron (ISO) (containing ≤0,02 % AMTT); 1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing ≤ 0,02 % AMTT)	604-291-0	142469-14-5	Skin Sens. 1
flufenacet (ISO);N-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide	604-290-5	142459-58-3	Acute Tox. 4; STOT RE 2; Skin Sens. 1
nitric acid, nickel salt	238-076-4	14216-75-2	Ox. Sol. 2; Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1
dinoterb (ISO); 2-tert-butyl-4,6-dinitrophenol	215-813-8	1420-07-1	Repr. 1B; Acute Tox. 2; Acute Tox. 3
trifenmorph (ISO);4-tritylmorpholine	215-812-2	1420-06-0	Acute Tox. 4
di-n-butyl ether; dibutyl ether	205-575-3	142-96-1	Flam. Liq. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
dodecyl methacrylate	205-570-6	142-90-5	STOT SE 3
dipropylamine	205-565-9	142-84-7	Flam. Liq. 2; Acute Tox. 4; Skin Corr. 1A
heptane; n-heptane	205-563-8	142-82-5	Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3

Je zobrazeno 2 801 - 3 000 položek z celkového počtu 4 691.

Export search results to:

EU-SAFETY_HEALTH_WORK-PREAMBLE

EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 30 dubna 2024. Database contains 4691 unique substances/entries.

Footer Nav Items